Affluent Medical | WebDisclosure

PRESS RELEASE

published on 04/04/2024 at 17:45, 1 year 11 months ago

Affluent Medical annonce l’initiation de couverture de son titre par Gilbert Dupont – Groupe Société Générale.
Affluent Medical annonce l'initiation de couverture de son titre par Gilbert Dupont - Groupe Société Générale. Gilbert Dupont recommande l'achat du titre d'Affluent Medical avec un objectif de cours de 3,30 €, un potentiel de hausse de 89%

Gilbert Dupont Affluent Medical MedTech Analyse Financière Initiation De Couverture
BRIEF

published on 03/28/2024 at 17:50, 1 year 11 months ago

Affluent Medical Stock Initiated by TP ICAP Midcap with Promising Outlook

Affluent Medical Financial Market MedTech TP ICAP Midcap Stock Coverage
BRIEF

published on 03/28/2024 at 17:50, 1 year 11 months ago

Un titre médical aisé lancé par TP ICAP Midcap avec des perspectives prometteuses

Marché Financier Technologie Médicale Médical Aisé TP ICAP Midcap Couverture Des Stocks
PRESS RELEASE

published on 03/28/2024 at 17:45, 1 year 11 months ago

Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap, with a target price of €3.20 and a potential upside of 87% according to the study 'Du baume au coeur'. The coverage adds to the financial analyst consensus

Affluent Medical Coverage Initiation TP ICAP Midcap Stock Clinical-phase MedTech
PRESS RELEASE

published on 03/28/2024 at 17:45, 1 year 11 months ago

Affluent Medical annonce l’initiation de couverture de son titre par TP ICAP Midcap.
Affluent Medical annonce l'initiation de couverture de son titre par TP ICAP Midcap, avec recommandation d'achat et objectif de cours de 3,20 €, représentant un potentiel de hausse de 87%

Affluent Medical MedTech TP ICAP Midcap Couverture De Titre Étude Financière
BRIEF

published on 03/12/2024 at 06:35, 2 years ago

Affluent Medical réussit la première implantation de son sphincter artificiel Artus

Affluent Medical MedTech Dispositif Médical Implantation Artus Incontinence Urinaire
BRIEF

published on 03/12/2024 at 06:35, 2 years ago

Affluent Medical successfully completes the first implantation of its Artus artificial sphincter

Medical Device Affluent Medical MedTech Artus Implementation Urinary Incontinence
PRESS RELEASE

published on 03/12/2024 at 06:30, 2 years ago

Affluent Medical annonce le succès de la première implantation chez l’homme de son sphincter artificiel Artus pour le traitement de l’incontinence urinaire d’effort.
Affluent Medical annonce le succès de la première implantation chez l'homme de son sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort

Affluent Medical Dispositif Médical Incontinence Urinaire Artus Implantation
PRESS RELEASE

published on 03/12/2024 at 06:30, 2 years ago

Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide

Medical Device Affluent Medical Urinary Incontinence Artus First-in-human Implantation
BRIEF

published on 02/29/2024 at 17:50, 2 years ago

Affluent Medical annonce des résultats positifs pour la valve Epygon

Affluent Medical Prothèses Médicales Valve Epygon Insuffisance Mitrale Biomimétique

Published on 03/26/2026 at 21:00, 1 hour 2 minutes ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 1 hour 2 minutes ago

Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 16:20, 5 hours 42 minutes ago

ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 14:05, 7 hours 57 minutes ago

SouthGobi Announces Profit Warning
Published on 03/26/2026 at 13:00, 9 hours 2 minutes ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor

View all ACCESSWIRE

Published on 03/26/2026 at 20:48, 1 hour 13 minutes ago

Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 2 hours 41 minutes ago

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:13, 2 hours 48 minutes ago

Director Declaration
Published on 03/26/2026 at 19:09, 2 hours 52 minutes ago

2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 2 hours 52 minutes ago

2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)

View all EQS

Published on 03/26/2026 at 18:17, 3 hours 45 minutes ago

Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 3 hours 45 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 4 hours 2 minutes ago

Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 4 hours 2 minutes ago

Calendrier financier 2026
Published on 03/26/2026 at 18:00, 4 hours 2 minutes ago

LABORATOIRES EUROMEDIS - Fin du contrat de liquidité

View all LES ECHOS COMFI WIRE

News